Mogrify has collected $17m in a second series A tranche led by Parkwalk Advisors to bring the round’s total to $33m.
Mogrify, a UK-based cell conversion technology developer with links to Bristol, Monash and Duke universities, secured $17m in a series A extension yesterday to bring the round’s total to $33m.
Parkwalk Advisors, the fund management subsidiary of commercialisation firm IP Group, led the second close, which also included Astellas Venture Management, the corporate venturing arm of pharmaceutical firm Astellas, 24Haymarket (1), Jonathan Milner and Darrin Disley.
Patient capital fund Ahren Innovation Capital led a $16m first tranche in…
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
